Overview

Epi-On Corneal Crosslinking for Keratoconus

Status:
Completed
Trial end date:
2019-09-30
Target enrollment:
Participant gender:
Summary
Epithelium-On Corneal Crosslinking for Keratoconus.
Phase:
Phase 4
Details
Lead Sponsor:
Comprehensive EyeCare of Central Ohio
Collaborators:
Avedro, Inc.
Glaukos Corporation
Treatments:
Flavin Mononucleotide
Riboflavin